René Jørgensen

Dr. René Jørgensen


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2004 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
CSChristian Mt Spahn
Christian Mt Spahn
MGMaria G Gomez‐Lorenzo
Maria G Gomez‐Lorenzo
RGRobert A Grassucci
Robert A Grassucci
Rene JørgensenRene Jørgensen
Rene Jørgensen
GAGregers R. Andersen
Gregers R. Andersen
JFJoachim Frank
Joachim Frank
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 October 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
DSDitte Marie Lindhardt Saunte
Ditte Marie Lindhardt Saunte
RHRasmus Krøger Hare
Rasmus Krøger Hare
KJKarin M. Jørgensen
Karin M. Jørgensen
Rene JørgensenRene Jørgensen
Rene Jørgensen
MDMette Deleuran
Mette Deleuran
Maiken ArendrupMaiken Arendrup
Maiken Arendrup
In recent years, cases involving terbinafine-resistant Trichophyton isolates have been reported increasingly, particularly in India. We present 14 cases of terbinafine treatment failure in Trichophyton -infected Danish patients due to acquired resistance. Patients infected with Trichophyton rubrum ( n = 12) or Trichophyton interdigitale ( n = 2) with elevated terbinafine MICs during 2013–2018 were included.

14 April 2003 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
Rene JørgensenRene Jørgensen
Rene Jørgensen
POPedro A. Ortiz
Pedro A. Ortiz
ACAnne Carr-Schmid
Anne Carr-Schmid
PNPoul Nissen
Poul Nissen
TKTerri Goss Kinzy
Terri Goss Kinzy
GAGregers R. Andersen
Gregers R. Andersen

1 August 2005 in Nature
Verified
Journal Article
Closed access
Rene JørgensenRene Jørgensen
Rene Jørgensen
AMAllan Rod Merrill
Allan Rod Merrill
SYSusan P. Yates
Susan P. Yates
VMVictor E. Marquez
Victor E. Marquez
ASAdrian L. Schwan
Adrian L. Schwan
GAGregers R. Andersen
Gregers R. Andersen

1 April 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Rene JørgensenRene Jørgensen
Rene Jørgensen
APAlexandra E. Purdy
Alexandra E. Purdy
RFRobert J. Fieldhouse
Robert J. Fieldhouse
MKMatthew S. Kimber
Matthew S. Kimber
DBDouglas H. Bartlett
Douglas H. Bartlett
AMA. Rod Merrill
A. Rod Merrill
The ADP-ribosyltransferases are a class of enzymes that display activity in a variety of bacterial pathogens responsible for causing diseases in plants and animals, including those affecting mankind, such as diphtheria, cholera, and whooping cough. We report the characterization of a novel toxin from Vibrio cholerae, which we call cholix toxin. The toxin is active against mammalian cells (IC(50) = 4.6 +/- 0.4 ng/ml) and crustaceans (Artemia nauplii LD(50) = 10 +/- 2 mug/ml). Here we show that this toxin is the third member of the diphthamide-specific class of ADP-ribose transferases and that it possesses specific ADP-ribose transferase activity against ribosomal eukaryotic elongation factor 2. We also describe the high resolution crystal structures of the multidomain toxin and its catalytic domain at 2.1- and 1.25-A resolution, respectively. The new structural data show that cholix toxin possesses the necessary molecular features required for infection of eukaryotes by receptor-mediated endocytosis, translocation to the host cytoplasm, and inhibition of protein synthesis by specific modification of elongation factor 2. The crystal structures also provide important insight into the structural basis for activation of toxin ADP-ribosyltransferase activity. These results indicate that cholix toxin may be an important virulence factor of Vibrio cholerae that likely plays a significant role in the survival of the organism in an aquatic environment.

1 February 2006 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
SYSusan P. Yates
Susan P. Yates
Rene JørgensenRene Jørgensen
Rene Jørgensen
GAGregers R. Andersen
Gregers R. Andersen
AMA. Rod Merrill
A. Rod Merrill